GlaxoSmithKline Pharmaceuticals Limited in the board meeting held on May 18, 2021 has recommended a dividend of INR 30/- per equity share on face value of INR 10 each for the year ended March 31, 2021, subject to approval of members at 96th Annual General Meeting. The Company has fixed July 20, 202 1 as the Record Date for determining entitlement of members to final dividend for the financial year ended March 31, 2021. The dividend, if approved by the members will be paid on or after July 27, 2021.